However, in a pathogenic context such as ageing or cisplatin exposure, the NOX3-derived ROS contribute significantly to morphological and functional consequences with destruction of the neurosensory cells in the cochlea and hearing loss (Rousset et al., 2015). The gene discussed is NOX3; the disease is hearing loss disorder.